Efficacy and safety of a therapeutic humanized FSH-blocking antibody in obesity and Alzheimer's disease models.
Pallapati AR, Korkmaz F, Rojekar S, Sims S, Misra A, Gimenez-Roig J, Gangadhar A, Laurencin V, Gumerova A, Cheliadinova U, Sultana F, Vasilyeva D, Cullen L, Schuermann J, Munitz J, Kannangara H, Parte S, Pevnev G, Burganova G, Tumoglu Z, Witztum R, Wizman S, Kramskiy N, Igel L, Sen F, Ranzenigo A, Macdonald A, Hutchison S, Teunissen AJ, Burkart H, Saxena M, Ginsburg Y, Goosens K, Zhou W, Ryu V, Moldavski O, Barak O, Pazianas M, Caminis J, Bhasin S, Fitzgerald R, Kim SM, Quinn M, Haider S, Appt S, Frolinger T, Rosen CJ, Lizneva D, Gupta YK, Yuen T, Zaidi M.
Pallapati AR, et al. Among authors: korkmaz f.
J Clin Invest. 2025 Jul 15;135(17):e182702. doi: 10.1172/JCI182702. eCollection 2025 Sep 2.
J Clin Invest. 2025.
PMID: 40663423
Free PMC article.